≡ Risteys
R8

Documentation Changelog GitHub Contact & Feedback

Glucosamine medication

PheWeb

RX_GLUCOSAMINE

No definition available.

Endpoint definition

↥
FinnGen phenotype data

356077 individuals

diagram downward connector

Apply sex-specific rule None

356077

diagram downward connector

Check conditions None

356077

diagram downward connector
diagram bullet

Filter registries

Medicine purchases: ATC M01AX05

36885

diagram downward connector

Check pre-conditions, main-only, mode, ICD version None

17102

diagram downward connector
diagram bullet

Check minimum number of events

Min. number of events 3

17102

diagram downward connector

Include endpoints None

17102

diagram downward connector
RX_GLUCOSAMINE

Extra metadata

First used in FinnGen datafreeze DF5

Summary Statistics

↥

Key figures

All Female Male
Number of individuals 17102 11991 5111
Unadjusted prevalence (%) 4.81 6.04 3.25
Mean age at first event (years) 60.51 60.02 61.68

Mortality

Follow-up Absolute risk HR [95% CI] p N
1998–2019 0.02 1.33 [1.15, 1.54] 1.4e-4 1757
15 years 0.01 1.23 [1.07, 1.42] 3.2e-3 1408
5 years 0.00 1.07 [0.92, 1.25] 4.0e-1 285
1 year 0.00 0.33 [0.19, 0.55] 2.4e-5 15

Age distribution of first events

Year distribution of first events

Cumulative Incidence

Correlations

↥

Index endpoint: RX_GLUCOSAMINE – Glucosamine medication
GWS hits: 2

Survival analyses between endpoints

↥

Plot

before Glucosamine medication
after Glucosamine medication

loading spinner Loading survival analyses plot

Drugs most likely to be purchased after Glucosamine medication

↥